Implicity

Paris, France  All France companies → — Founded 2016
Specialty-Focused AI Wearables / RPM
Cardiology Hospital Medicine
Cardiology AI Wearables & Remote Monitoring (RPM)
Series A, with additional grant funding — $30.7 million
Website Claim this company

Products

IM007
Implicity
Cardiology AI
Implicity offers an FDA-cleared, AI-powered, cloud-based platform for remote cardiac monitoring. It aggregates data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management. Note: This tool is a remote cardiac monitoring platform, not a physician directory.
Contact for pricing
SignalHF
Implicity
Cardiology AI
SignalHF by Implicity is an FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care.
Contact for pricing
Implicity ILR ECG Analyzer
Implicity
Cardiology AI
Implicity's AI-powered platform provides smart remote monitoring solutions for cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), enhancing arrhythmia detection and optimizing clinical workflows.
Contact for pricing

See all 3 products →

About Implicity

Implicity is a leading digital MedTech software company that offers advanced remote monitoring and cardiac data management solutions for patients with cardiac implantable electronic devices (CIEDs) and heart failure. Their universal, AI-driven platform is designed to integrate and standardize data from all major CIED manufacturers into a single, comprehensive view, thereby simplifying the interpretation of remote monitoring data for medical staff. This platform leverages sophisticated AI and machine learning algorithms to significantly reduce alert fatigue by filtering out non-clinically relevant events, allowing physicians and care teams to focus on critical patient management and accelerate diagnosis.

Key features include FDA-cleared AI algorithms like Signal HF, which predicts the risk of heart failure hospitalization, and ILR ECG Analyzer, which reduces false positives in Insertable Cardiac Monitor (ICM) ECG recordings. By streamlining workflows, optimizing productivity, and providing predictive intelligence, Implicity aims to improve clinical outcomes, enhance patient care, and support the future of preventive medicine in cardiology. Implicity’s solutions are associated with superior patient outcomes, including reduced mortality and hospitalization length, compared to conventional remote monitoring.

Focus Areas

Remote cardiac monitoring AI-based algorithms cardiac implantable electronic devices (CIEDs) heart failure management arrhythmia detection false positive reduction cardiac data management predictive medicine clinical workflow optimization

Business Intelligence

Key InvestorsCrédit Mutuel Innovation, Bpifrance, BNP Paribas Development, Serena, XAnge, Karista
PartnershipsIronRod Health, Withings, Bayer HealthCare SAS France, Epic (EHR integration)
TechnologyCloud-native, AI-driven, machine learning, knowledge graphs, semantic web technologies, device-agnostic data aggregation and standardization platform
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Remote Cardiac Monitoring
Implicity offers a universal, cloud-based platform that consolidates and standardizes data from all major Cardiac Implantable Electronic Device (CIED) manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort) into a single interface. This approach has been associated with a 26% reduced mortality and a 4% reduction in hospitalization length compared to conventional remote monitoring.
AI-based Algorithms
The platform leverages FDA-cleared AI algorithms to provide accurate, actionable data and significantly reduce 'noise' and alert fatigue. Key algorithms include Signal HF for forecasting heart failure hospitalization risk, and ILR ECG Analyzer which reduces false positives by up to 79% in ILR ECG recordings while maintaining high sensitivity.
Cardiac Implantable Electronic Devices (CIEDs) Management
Implicity simplifies CIED alert management by integrating all device data into a unified system, eliminating manual data transfers and allowing clinic staff to easily review alerts and assign actions.
Heart Failure Management
Utilizing the FDA-cleared Signal HF algorithm, Implicity proactively identifies high-risk patients for heart failure hospitalization. The platform also integrates with connected devices like Withings smart scales to monitor for sudden weight gain, a key indicator of worsening heart failure, and automatically alerts medical teams.
Arrhythmia Detection & False Positive Reduction
Implicity's AI-driven AF Alert Management detects clinically relevant events, leading to an 85% decrease in unnecessary Atrial Fibrillation burden alerts. The ILR ECG Analyzer further reduces false positives in ECG recordings by 79%.
Cardiac Data Management
The platform centralizes and standardizes vast amounts of discrete raw cardiac data from various manufacturers, making it readily available for clinical review, performance analytics, and research purposes.
Predictive Medicine
Through its AI capabilities, particularly the Signal HF algorithm, Implicity offers predictive intelligence to identify patients at risk of adverse cardiac events, such as heart failure hospitalization, enabling proactive intervention.
Clinical Workflow Optimization
Implicity automates routine tasks, reduces alert fatigue, and streamlines processes like billing workflows and reporting, leading to increased staff productivity and more time for critical patient management.
Research Capabilities
The platform provides an Advanced Research Tool that allows access to raw, normalized patient data across manufacturers, supports customized eCRFs, and facilitates patient consent tracking for clinical studies. Implicity is the official remote monitoring platform for a large European research consortium on ICDs.
Physician Tip

For physicians, Implicity stands out by offering a unified, AI-powered platform that cuts through the noise of remote cardiac monitoring data. You gain clinical confidence from FDA-cleared algorithms that deliver accurate, actionable insights, significantly reducing false positives and alert fatigue. This translates to reclaimed time, allowing you to focus on critical patient management and make faster, more informed diagnostic and treatment decisions. The predictive intelligence, especially for heart failure, enables proactive care, while the device-agnostic nature ensures a comprehensive view of all your CIED patients, regardless of manufacturer. Ultimately, Implicity aims to elevate patient outcomes through smarter, more efficient cardiac care.

Implicity is designed for seamless interoperability. It offers comprehensive API and integration frameworks for bidirectional data exchange with core hospital systems, including Electronic Health Record (EHR) systems like Epic (via a Smart on FHIR app). The platform also supports integration with other connected health devices, such as Withings smart scales for heart failure management.

Products by Implicity

3 products in the directory

IM007
Implicity
Cardiology AI
Implicity offers an FDA-cleared, AI-powered, cloud-based platform for remote cardiac monitoring. It aggregates data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management. Note: This tool is a remote cardiac monitoring platform, not a physician directory.
Contact for pricing
SignalHF
Implicity
Cardiology AI
SignalHF by Implicity is an FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care.
Contact for pricing
Implicity ILR ECG Analyzer
Implicity
Cardiology AI
Implicity's AI-powered platform provides smart remote monitoring solutions for cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), enhancing arrhythmia detection and optimizing clinical workflows.
Contact for pricing

Reviews & Opinions

No web reviews on file yet for Implicity. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Implicity.

Loading videos...

Videos load interactively. If none appear, search YouTube for Implicity →

View all on YouTube

Press & Coverage

Implicity (via PR Newswire)
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
Implicity received 510(k) clearance from the U.S. FDA for SignalHF, a new algorithm that predicts heart failure hospitalizations by analyzing data from cardiac remote monitoring devices. This tool aims to enable earlier interventions and reduce hospital admissions.
2024-05
PR Newswire
Implicity's EVIDENCE-RM Study Demonstrates Marked Improvement in ICD Patient Outcomes
The EVIDENCE-RM study, published in Heart Rhythm, showed that Implicity's universal monitoring system significantly reduced mortality by 26% and decreased hospitalizations for patients with implantable cardioverter-defibrillators (ICDs) compared to manufacturer-specific systems.
2025-04
GlobeNewswire
Study Shows Implicity's New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices
New findings presented at Heart Rhythm Society (HRS) 2026 indicate that Implicity's cloud-based AI algorithm can further reduce false-positive alerts in implantable loop recorders (ILRs) by 61.6% while maintaining high sensitivity, even after initial manufacturer filtering.
2026-04
Implicity (via PR Newswire)
IMPLICITY Raises $23M to Broaden Use of Its Cardiac Remote Monitoring Platform
Implicity announced a $23 million Series A funding round to accelerate the international rollout of its AI-based technology and cardiac data management solutions, particularly in the US market.
2022-04
Implicity (via PR Newswire)
New Study Published in Cardiovascular Digital Health Journal Shows Implicity's Algorithm Significantly Reduces AF Alert Burden in Remote Cardiac Monitoring
A clinical study published in the Cardiovascular Digital Health Journal demonstrated that Implicity's algorithm significantly reduced atrial fibrillation (AF) alert burden in remotely monitored patients by filtering non-clinically relevant alerts.
2023-10
Implicity (via PR Newswire)
Implicity Receives FDA Clearance for AI-Powered ECG Analyzer for Implantable Loop Recorders
Implicity received FDA clearance for its AI-powered ILR ECG Analyzer, a medical algorithm designed to analyze ECG data from Implantable Loop Recorders and reduce false-positive detections of atrial fibrillation.
2021-12
Implicity
Implicity Introduces New Algorithm to Address Alert Fatigue in AF Care
Implicity launched a new algorithm to reduce alert fatigue in the remote monitoring of atrial fibrillation (AF) patients by focusing on clinically significant events and reducing the volume of non-actionable alerts.
2023-04
Implicity
Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
Implicity expanded its product line with a new dedicated heart failure solution, an AI-based tool developed in collaboration with Withings, which integrates data from various cardiac devices and smart scales to alert care teams to worsening conditions.
2026-06

Frequently Asked Questions

Implicity offers a cloud-based, AI-driven platform that unifies data from all major cardiac implantable electronic device (CIED) manufacturers into a single view, streamlining the review process. Its FDA-cleared AI algorithms, such as the ILR ECG Analyzer and AF Alert Management, significantly reduce false positive alerts by up to 79% and unnecessary AF alerts by 85%, allowing physicians to focus on clinically relevant events and optimize their workflow.
Implicity provides FDA-cleared AI algorithms like the ILR ECG Analyzer for arrhythmia detection, which reduces false positives in implantable loop recorder (ILR) ECGs by 79% while maintaining 99% sensitivity. For heart failure management, their SignalHF algorithm predicts heart failure hospitalizations within 30 days by analyzing physiological and device data, enabling proactive interventions and improved patient outcomes.
Implicity's platform optimizes clinical workflows by automating routine tasks, simplifying CIED alert management, and providing real-time access to patient data. It integrates with Electronic Health Record (EHR) systems like Epic via a SMART on FHIR app, ensuring seamless data flow and reducing the burden of manual data transfers for clinic staff and IT teams.
Implicity's solutions are FDA-cleared, including their AI algorithms like SignalHF and ILR ECG Analyzer. The platform is also fully compliant with data privacy regulations such as HIPAA and GDPR, and holds ISO 27001 and Health Data Hosting (HDS) certifications, ensuring high standards of data security and protection.
Yes, Implicity's platform is device-agnostic and designed to aggregate and standardize data from all major CIED manufacturers, including Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort. It also integrates with EHR systems through a SMART on FHIR application, ensuring interoperability and a unified view of patient data within existing hospital IT infrastructure.
Implicity provides comprehensive customer support, including a dedicated Customer Success team for onboarding, training, hotline assistance, and ongoing guidance to maximize platform utilization. They also engage in strategic partnerships, such as a distribution agreement with MicroPort CRM and collaborations with companies like Withings for heart failure solutions, to expand their reach and enhance their offerings.
Founded in 2016 by a cardiac electrophysiologist, Implicity has demonstrated strong growth, monitoring over 70,000 patients across more than 100 medical facilities in the US and Europe. The company secured $23 million in Series A funding in April 2022, bringing its total funding to $28 million, which is being used to accelerate international expansion and further develop its AI-based medical algorithms, indicating a stable and growth-oriented future.

Investors

Who's funded Implicity.

Serena
VC T3
Paris, France
$1M-$5M
Serena is a Paris-based generalist venture firm investing across consumer technology, B2B software, fintech, and selectively in health technology, with a portfolio…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services

Comparisons

BrightHeart View Classifier vs Implicity ILR ECG Analyzer
IM007 vs Sleepiz One+
IM007 vs EchoNext
IM007 vs PMcardio

Related Companies

CAIMed (Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin)
Hannover, Germany (Lower Saxony region)

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm
Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA
London, UK

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
London, United Kingdom

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI
Canberra, ACT, Australia

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART
Boizenburg / Elbe, Germany

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.